OJPed  Vol.2 No.1 , March 2012
Orbital pseudotumor: A single precursor clinical manifestation of Wegener granulomatosis in a ten year old boy
Wegener granulomatosis (WG) is a type of vasculitis characterized by the presence of anti-neutrophil cy-toplasmic antibodies (ANCA) and inflammation of small and medium sized vessels with granulomas formation. Most commonly affected organs include upper and lower respiratory tract, kidneys, eyes, nervous system and skin. Kidneys’ involvement has a central position in the classification, diagnosis, treatment and prognosis of patients with WG, and is characterized by the presence of necrotic glomerulonephritis and clinical manifestations that vary from microscopic hematuria to acute renal insufficiency. We describe a case report of a ten year old boy presenting with microscopic hematuria of glomerular origin and a medical history of orbital pseudotumor two years before his hospitalization due to renal symptoms. Renal biopsy revealed lesions of pauci-immune glome-rulonephritis and findings of granulomatous inflam-mation and necrotizing vasculitis. Serum was positive for p-ANCA antibodies (perinuclear staining pattern ANCA antibodies). These findings led to the diagnosis of WG of generalized form (according to EULAR/ PRINTO/PRES criteria). The patient has been treated with aggressive immunotherapy with the use of ster-oids, cyclophosphamide and mycophenolate mofetil. Disease remission has been established and retained one year after initial diagnosis. Orbital pseudotumor, which is a diagnosis of exclusion, has been the initial disease’s clinical manifestation, even though at that time neither the ocular biopsy nor the immunologic workup had been indicative in terms of WG. Although WG is very rare in children, this disease should always been included in the differential diagnosis in patients with similar clinical manifestations and clinicians should emphasize on the recognition of granulomatous vasculitis in biopsies as well as on repeated tests for ANCA antibodies’ detection in serum. High morbidity and mortality rates [1] of this clinical entity necessitates the early recognition of atypical disease’s forms and the close follow up in cases of uncertain initial diagnosis.

Cite this paper
Maggina, P. , Askiti, V. , Maurikou, M. , Mila, M. , Papadatos, D. , Stamogianou, L. and Stefanidis, C. (2012) Orbital pseudotumor: A single precursor clinical manifestation of Wegener granulomatosis in a ten year old boy. Open Journal of Pediatrics, 2, 56-59. doi: 10.4236/ojped.2012.21009.
[1]   Frosch, M. and Foell D. (2004) Wegener granulomatosis in childhood and adolescence. European Journal of Pediatrics, 163, 425-434. doi:10.1007/s00431-004-1464-3

[2]   Cabral, D.A., et al. (2009) Classification, presentation, and initial treatment of Wegener’s granulomatosis in childhood. Arthritis & Rheumatism, 60, 3413-3424. doi:10.1002/art.24876

[3]   Jayne, D. (2009) Review article: Progress of treatment in ANCA-associated vasculitis. Nephrology (Carlton), 14, 42-48. doi:10.1111/j.1440-1797.2009.01101.x

[4]   Westman, K.W., et al. (1998) Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. Journal of the American Society of Nephrology 9, 842-852.

[5]   Roberti, I., Reisman, L. and Churg, J. (1993) Vasculitis in childhood. Pediatric Nephrology, 7, 479-489. doi:10.1007/BF00857580

[6]   Rottem, M., et al. (1993) Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. Journal of Pediatrics, 122, 26-31. doi:10.1016/S0022-3476(05)83482-1

[7]   Stegmayr, B.G., et al. (2000) Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatric Nephrology, 14, 208-213. doi:10.1007/s004670050043

[8]   Atkin, S.R. (1990) Orbital pseudotumor, differential diagnosis. Optometry & Vision Science, 67, 840-844. doi:10.1097/00006324-199011000-00009

[9]   The Johns Hopkins Hospital (2008) The Harriet Lane handbook: A manual for Pediatric House Officers.

[10]   Vanoni, F., et al. (2010) Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatric Nephrology, 25, 205-212. doi:10.1007/s00467-009-1253-3

[11]   Mukhtyar, C., et al. (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Annals of the Rheumatic Diseases, 68, 310- 317. doi:10.1136/ard.2008.088096

[12]   Pallan, L., Savage, C.O. and Harper, L. (2009) ANCA-associated vasculitis: From bench research to novel treatments. Nature Reviews Nephrology, 5, 278-286. doi:10.1038/nrneph.2009.45

[13]   Rigante, D. (2006) Clinical overview of vasculitic syndromes in the pediatric age. European Review for Medical and Pharmacological Sciences, 10, 337-345.

[14]   Nash, M.C. and Dillon, M.J. (1997) Antineutrophil cytoplasm antibodies and vasculitis. Archives of Disease in Childhood, 77, 261-264. doi:10.1136/adc.77.3.261

[15]   Brown D.H, MacRae, D.L. and Allen, L.H. (1998) Orbital Pseudotumors. Journal of Otolaryngology, 17, 164- 168.

[16]   Wung, P.K. and Stone, J.H. (2006) Therapeutics of Wegener’s granulomatosis. Nature Clinical Practice Rheumatology, 2, 192-200. doi:10.1038/ncprheum0139